Matrix metalloproteinases, the pros and cons, in liver fibrosis
about
Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosisHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverTumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1.Protective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy.The interaction between mesenchymal stem cells and steroids during inflammation.Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesisCloning and expression of ADAM-related metalloproteases in equine laminitisDaily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation.Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection.Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia.Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applicationsPhosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarctionMMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays.The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease.Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantationMatrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosisStaging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver.Matrix metalloproteinases in liver injury, repair and fibrosis.IL-1β enhances cell adhesion to degraded fibronectin.Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth.A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix.Liver fibrosis: searching for cell model answers.A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.Liver Injury and the Activation of the Hepatic Myofibroblasts.Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient miceInterleukin-1 participates in the progression from liver injury to fibrosis.Collapsed Reticular Network and its Possible Mechanism during the Initiation and/or Progression of Hepatic FibrosisPutative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.Myofibroblastic cell activation and neovascularization predict native liver survival and development of esophageal varices in biliary atresia.Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapiesBile duct basement membrane thickening in primary sclerosing cholangitis.The role of iNOS in cholesterol-induced liver fibrosis.Liver diseases: what is known so far about the therapy with human amniotic membrane?A complex role of activin A in non-alcoholic fatty liver disease.Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow.Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C.The differential effects of low birth weight and Western diet consumption upon early life hepatic fibrosis development in guinea pig.
P2860
Q26744390-23BF954A-9E16-436E-98E8-F2B214D4560BQ29616840-2089867E-5026-41C5-B327-664A62961758Q33419704-7197E9EB-5623-46FA-8188-A364B05713E0Q33594283-71652FAF-2EE6-4101-B4C5-5D18F1AE69F1Q33695051-3FE3F4E0-8C1E-44C8-B822-21B26DBE9593Q33976028-B6B3B4AD-CF02-4A8C-8F5E-77ED542E07DAQ34009507-5D3C6549-ED1B-4D3B-91ED-FC0F1E6BA561Q34246947-72DD4858-DB08-451E-8603-E08977E3BCA6Q34252987-8C725BC0-5B2A-4BF9-BCC6-FD0F61B4D2BDQ34256849-477DEF35-92BD-4C44-A442-960770E737F3Q34476390-48C9C834-DBA3-488B-B4A9-0D1490DEB94CQ34515203-00B2219C-AB1D-4946-B9B8-5455E545595AQ35078379-D47C52A8-4512-41DB-9477-4A6D87DB1FB4Q35078509-36BD30A3-9A3F-4A2E-AE36-AF641B7A9499Q35081469-25D196D1-0802-4172-A6CD-D6A872DC33ECQ35168136-6138A2A1-9BA7-4340-B709-7F216610B7C1Q35219977-FC7C605D-8C9C-489F-82A6-39C3599B76B8Q35237338-359D6682-7578-4ED8-BBFD-6C3633F0D9A6Q35246561-A21CE315-97BF-47CB-9423-BA34F9B51859Q35830977-468DBD4D-0CB4-4985-A639-79DBFDCB685EQ36329738-C2EAFF0E-6261-4D74-A412-7187CBB74189Q36521527-BEEE30CF-FFA9-43AD-93BD-996F0ABA8F06Q36647946-0F139483-4479-4615-B88A-399040F6D07AQ36777935-9B4700E5-EC52-46E1-94A8-58DC66E62235Q36905046-19884521-41B8-4A6A-9B55-1C866875C8F1Q36926517-7FFA2258-8361-42BC-A0A3-BD4B96E42C2EQ37109402-10F6CBE5-846C-4A0D-A2A2-AAECA89561BDQ37138759-A82D1AB6-0A56-4CDC-94D0-A51C75FBEDC8Q37231308-42F66970-0C50-4A02-AE1D-BAF18F79014AQ37339900-AB2D31D0-0662-4A7E-9BB5-F60A8DCAFE45Q37388018-4BAC5B5C-9963-462E-A6A0-7F2F6E3FFF4EQ37660702-FFA65B0E-678E-4B6B-A561-8F1CD00718C9Q38073028-8C511009-2B4B-42E4-8D00-E9379493B1F2Q38384631-A8728435-47A3-47FB-9BFA-3D6B93576069Q38861311-A123AE22-8730-4086-8C97-3118834E9478Q38934348-60E97B0F-F2A5-413D-B0A7-9DADF99466F3Q39837123-5567F8B6-244F-4D6E-81FD-B313AF3C25AEQ39846145-E7E92975-4509-48F6-8103-FE9CB0B6D02CQ40211269-1207DF2A-4B1C-4CFA-9D5C-C1F3C4D09D96Q40216300-DC7AB50D-A082-46EA-9BCF-4B9AF62B531B
P2860
Matrix metalloproteinases, the pros and cons, in liver fibrosis
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Matrix metalloproteinases, the pros and cons, in liver fibrosis
@ast
Matrix metalloproteinases, the pros and cons, in liver fibrosis
@en
type
label
Matrix metalloproteinases, the pros and cons, in liver fibrosis
@ast
Matrix metalloproteinases, the pros and cons, in liver fibrosis
@en
prefLabel
Matrix metalloproteinases, the pros and cons, in liver fibrosis
@ast
Matrix metalloproteinases, the pros and cons, in liver fibrosis
@en
P2860
P921
P1476
Matrix metalloproteinases, the pros and cons, in liver fibrosis
@en
P2093
Yuan-Ping Han
P2860
P304
P356
10.1111/J.1440-1746.2006.04586.X
P478
21 Suppl 3
P577
2006-10-01T00:00:00Z